These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24561658

  • 1. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
    Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
    [Abstract] [Full Text] [Related]

  • 2. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
    Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
    [Abstract] [Full Text] [Related]

  • 3. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.
    Cramer JA, Wang ZJ, Chang E, Copher R, Cherepanov D, Broder MS.
    Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369
    [Abstract] [Full Text] [Related]

  • 4. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
    Manjunath R, Paradis PE, Parisé H, Lafeuille MH, Bowers B, Duh MS, Lefebvre P, Faught E.
    Neurology; 2012 Oct 30; 79(18):1908-16. PubMed ID: 23077014
    [Abstract] [Full Text] [Related]

  • 5. Clinical and economic burden of breakthrough seizures.
    Divino V, Petrilla AA, Bollu V, Velez F, Ettinger A, Makin C.
    Epilepsy Behav; 2015 Oct 30; 51():40-7. PubMed ID: 26255884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE, Weiner JR, Guérin A, Cunnington MC, Duh MS.
    Epilepsia; 2009 Mar 30; 50(3):501-9. PubMed ID: 19183224
    [Abstract] [Full Text] [Related]

  • 9. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
    Borghs S, Byram L, Chan J, Dedeken P, Logan J, Kiri V, Noack-Rink M, Patsalos PN, Thieffry S.
    BMC Neurol; 2020 Jan 08; 20(1):7. PubMed ID: 31914953
    [Abstract] [Full Text] [Related]

  • 10. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
    Ip Q, Malone DC, Chong J, Harris RB, Labiner DM.
    Epilepsy Behav; 2018 Mar 08; 80():208-214. PubMed ID: 29414554
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY, Wu N, Boulanger L, Sacco P.
    J Med Econ; 2013 Mar 08; 16(2):240-8. PubMed ID: 23171361
    [Abstract] [Full Text] [Related]

  • 13. Payer costs of patients diagnosed with epilepsy.
    Griffiths RI, Schrammel PN, Morris GL, Wills SH, Labiner DM, Strauss MJ.
    Epilepsia; 1999 Mar 08; 40(3):351-8. PubMed ID: 10080518
    [Abstract] [Full Text] [Related]

  • 14. Claims data analyses unable to properly characterize the value of neurologists in epilepsy care.
    Hill CE, Lin CC, Burke JF, Kerber KA, Skolarus LE, Esper GJ, Magliocco B, Callaghan BC.
    Neurology; 2019 Feb 26; 92(9):e973-e987. PubMed ID: 30674587
    [Abstract] [Full Text] [Related]

  • 15. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
    Fishman J, Martin M, Labiner DM, Lew CR, Johnson BH.
    Epilepsy Behav; 2019 Oct 26; 99():106331. PubMed ID: 31399339
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E.
    Eur J Paediatr Neurol; 2012 Sep 26; 16(5):449-58. PubMed ID: 22261080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comprehensive care of the epilepsy patient--control, comorbidity, and cost.
    Bazil CW.
    Epilepsia; 2004 Sep 26; 45 Suppl 6():3-12. PubMed ID: 15315510
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of two methods for estimating the health care costs of epilepsy.
    Frost FJ, Hurley JS, Petersen HV, Gunter MJ, Gause D.
    Epilepsia; 2000 Aug 26; 41(8):1020-6. PubMed ID: 10961630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.